Jeffrey B. Mirviss - 16 Feb 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP&Pres, Periph Intervent
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
16 Feb 2023
Net transactions value
-$297,809
Form type
4
Filing time
21 Feb 2023, 15:19:32 UTC
Previous filing
16 Feb 2023
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +2,970 +3.3% $0.000000 92,858 16 Feb 2023 Direct F1
transaction BSX Common Stock Tax liability $42,250 -909 -0.98% $46.48 91,949 16 Feb 2023 Direct
transaction BSX Common Stock Sale $65,927 -1,409 -1.5% $46.79 90,540 16 Feb 2023 Direct F2
transaction BSX Common Stock Options Exercise $0 +3,333 +3.7% $0.000000 93,873 17 Feb 2023 Direct F1
transaction BSX Common Stock Tax liability $47,471 -1,020 -1.1% $46.54 92,853 17 Feb 2023 Direct
transaction BSX Common Stock Sale $95,527 -2,061 -2.2% $46.35 90,792 17 Feb 2023 Direct F2
transaction BSX Common Stock Options Exercise $0 +2,817 +3.1% $0.000000 93,609 18 Feb 2023 Direct F3
transaction BSX Common Stock Tax liability $46,633 -1,002 -1.1% $46.54 92,607 18 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -2,970 -25% $0.000000 8,910 16 Feb 2023 Common Stock 2,970 Direct F1, F4
transaction BSX Restricted Stock Units Options Exercise $0 -3,333 -33% $0.000000 6,667 17 Feb 2023 Common Stock 3,333 Direct F1, F5
transaction BSX Deferred Stock Units Options Exercise $0 -2,817 -50% $0.000000 2,817 18 Feb 2023 Common Stock 2,817 Direct F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F3 Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F5 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F6 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.